Open access · Peer reviewed · Scopus journal
Recurrence of atrial fibrillation after switching from brand to generic atenolol
- 1*,
- 1,
- 1,
- 1,
- 1,
- 1
- 1Giovambattista De Sarro Department of Health Science, University of Catanzaro, Catanzaro, Italy.
Published in Journal of Pharmacology and Pharmacotherapeutics
Correspondence: Luca Gallelli
Giovambattista De Sarro Department of Health Science, University of Catanzaro, Catanzaro, Italy.
Email: gallelli@unicz.it
Copyright: © 2014 The Author(s). This is an open access article.
Published: Jan 1, 2014, Received: Jan 23, 2014, Accepted: Jun 28, 2014
Abstract
Beta blockers are the initial treatment for rate control of supraventricular tachyarrhythmia in patients without a history of myocardial infarction or left ventricular dysfunction. In this article we report the recurrence of atrial fibrillation after switching to the generic formulation of atenolol.
Keywords
Subject
Recommended articles
- Effect of losartan and atenolol on insulin sensitivity in nondiabetic hypertensive patients
Sandesh Madhukar Bharati, Nishith Singh · Journal of Pharmacology and Pharmacotherapeutics
- The new factor Xa inhibitor: Apixaban
Sangeeta Bhanwra, Kaza Ahluwalia · Journal of Pharmacology and Pharmacotherapeutics
- Oral carvedilol in escalating doses in the acute treatment of atrial fibrillation
Ravi Venkatachelam Chitrapu, Pentakota Ramana Rao, Gangireddy Venkateswara Reddy · Journal of Pharmacology and Pharmacotherapeutics
Readers Also Viewed
Pharmacogenomics Meets Generative AI: Transforming Clinical Trial Design with Large Language Models
Annisa Fatharani, Ali Alsayegh
Jan 1, 2026
Clinical Outcomes and Management of Post-varicocelectomy on Male Fertility: A Comprehensive Review
Mohammad Akbar Hossain
Jan 1, 2026
Knowledge, Attitude, and Practice on Digital Eye Strain Among Healthcare Students at a Private University in Northern Peninsular Malaysia
Lim Chin Hung, Subramani Parasuraman, Sam Aaseer Thamby
Jan 1, 2026